株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医薬品有効成分 (API) の世界市場

Global Active Pharmaceuticals Ingredients Market - 2018-2025

発行 DataM Intelligence 商品コード 792794
出版日 ページ情報 英文 130-180 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.32円で換算しております。
Back to Top
医薬品有効成分 (API) の世界市場 Global Active Pharmaceuticals Ingredients Market - 2018-2025
出版日: 2019年02月01日 ページ情報: 英文 130-180 Pages
概要

当レポートでは、世界の医薬品有効成分 (API) 市場について調査分析し、産業分析、市場分析、地域別分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 調査手法・範囲

第2章 世界の医薬品有効成分 (API) 市場:動向

  • 主要動向と発展

第3章 世界の医薬品有効成分 (API) 市場:産業分析

  • 産業への影響要因 (促進要因・抑制要因)
  • 競合の集中度:ポーターのファイブフォース分析
  • 規制分析

第4章 世界の医薬品有効成分 (API) 市場:市場分析

  • 種類別
    • 合成API
    • バイオテクノロジーAPI
  • 性質別
    • ジェネリックAPI
    • 画期的API
  • 製造タイプ別
    • キャプティブ
    • マーチャント
  • 用途別
    • 心血管
    • 糖尿病
    • 腫瘍
    • 整形外科
    • 神経学
    • NSAIDS
    • その他

第5章 世界の医薬品有効成分 (API) 市場:地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • その他

第6章 世界の医薬品有効成分 (API) 市場:競合情勢

  • 市場シェア分析
  • 主な戦略
  • 製品ベンチマーキング

第7章 企業プロファイル

  • Aurobindo Pharma
  • Mylan
  • Teva Active Pharmaceutical Ingredients
  • Ipca
  • Aceto Corporation
  • Arevipharma GmbH
  • Dr. Reddy's
  • Pfizer, Inc
  • Novartis International AG
  • Sanofi
  • Ranbaxy
  • Sun Pharma

第8章 付録

目次

Active Pharmaceutical Ingredients Market

The Active Pharmaceutical Ingredients Market Size was valued at USD xx million in 2016 and USD xx million in 2017 .

The market forecast for the year 2025 is pegged at USD xx million, with a CAGR of xx% during the period (2018-2025).

Global Active Pharmaceuticals Ingredients Market: Segmentation

The Active Pharmaceutical Ingredients Market Size is segmented based on Type, Nature, Application, and Manufacturing type.

By type, the market is divided into Synthetic API and Biotech API.

Biotech APIs include Monoclonal Antibodies, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Recombinant Enzymes, Antibiotics, Statins, and Others.

By Manufacturing type, the market is divided into Captive and Merchant.

Captive API is the largest segment covering a significant part of the global API market with a market share of approximately 61% while the remaining is taken by Merchant API.

By End User, the market is classified into-Patients with chronical diseases, Physicians, Hetero Labs, Pharmaceutical companies, Hospitals, Parents/Relatives, and Others.

Based on Nature into Generic API and Innovator API.

Based on Application as Cardiovascular, Diabetes, Oncology, Orthopaedics, Neurology, NSAIDS, and Others.

The scope of the report:

This Active Pharmaceutical Ingredients Report covers factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and Company Profiles.

The report profiles various companies including Aurobindo Pharma, Mylan, Teva Active Pharmaceutical Ingredients, Ipca, Hetero Labs, Pharmaceutical companies Aceto Corporation, Arevipharma GmbH, Dr. Reddy's Laboratories, Pfizer, Inc, Novartis International AG, Sanofi, Ranbaxy, and Sun Pharma.

What are the key factors driving the global active pharmaceutical ingredients market?

Aurobindo Pharma has the highest Active Pharmaceutical Ingredients Market Share.

Patent expiration of a drug leads to its generic version and the manufacturers bear the cost.

This decreases the overall cost of the ingredient thereby increasing the number of users, which further increases the global market for the parts.

For instance, the patent for Teva's long-acting MS med Copaxone 40 mg, which has a revenue of $3.48 billion in the U.S. expired allowing the manufacturers to use the technology and produce the drug leading to an increase in production from 80% to 85%.

Patent expiries of the branded drugs, increased uptake of biologics, government initiatives for biomedical research are majorly driving the global Active Pharmaceutical Ingredients Market. However, Unfavourable Drug Price Control Policies Across Various Countries is holding back the growth of the market.

Regional Insights:

The report segments the geographies by region, which include North America, South America, Europe, Asia Pacific, and RoW.

North America dominates the Global Active Pharmaceutical Ingredients Market with a share of approximately 40.1%, followed by Europe with 24%.

Increasing medical requirements, advancement in R&D and innovations in this regions are favoring the growth of the market.

Why purchase the Active Pharmaceutical Ingredients Report?

Visualization of Active Pharmaceutical Ingredients Market composition across each indication, regarding type and applications, highlighting the critical commercial assets and players.

Identification of commercial opportunities in Active Pharmaceutical Ingredients by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of market level 4/5 segmentation

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study

Product mapping in excel for crucial products of all major market players

Table of Contents

Chapter 1 Global Active Pharmaceutical Ingredients Market: Methodology and Scope

  • 1.1 Research methodology
  • 1.2 Scope of the Report

Chapter 2 Global Active Pharmaceutical Ingredients Market-Trends

  • 2.1 Key Trends & Developments

Chapter 3 Global Active Pharmaceutical Ingredients Market-Industry Analysis

  • 3.1 Industry Impact Factors (Drivers & Restraints)
  • 3.2 Competitive Intensity- Porter 5 Forces
  • 3.3 Regulatory Analysis

Chapter 4 Global Active Pharmaceutical Ingredients Market-Market Analysis

  • 4.1. Active Pharmaceutical Ingredients Market By Type
    • 4.1.1. Synthetic API
    • 4.1.2. Biotech API
  • 4.2. Active Pharmaceutical Ingredients Market- By Nature
    • 4.2.1. Generic API
    • 4.2.2. Innovator API
  • 4.3. Active Pharmaceutical Ingredients Market- By Manufacturing type
    • 4.3.1. Captive
    • 4.3.2. Merchant
  • 4.4. Active Pharmaceutical Ingredients Market- By Application
    • 4.4.1. Cardiovascular
    • 4.4.2. Diabetes
    • 4.4.3. Oncology
    • 4.4.4. Orthopaedics
    • 4.4.5. Neurology
    • 4.4.6. NSAIDS
    • 4.4.7. Others

Chapter 5 Global Active Pharmaceutical Ingredients Market-Geographical Analysis

  • 5.1. North America
    • 5.1.1. The USA
    • 5.1.2. Canada
    • 5.1.3. Mexico
  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. The UK
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Rest of Europe
  • 5.3. Asia Pacific
    • 5.3.1. China
    • 5.3.2. Japan
    • 5.3.3. India
    • 5.3.4. Australia
    • 5.3.5. Rest of Asia Pacific
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5. RoW

Chapter 6 Global Active Pharmaceutical Ingredients Market-Competitive Landscape

  • 6.1. Market Share Analysis
  • 6.2. Key Strategies
  • 6.3. Product Benchmarking

Chapter 7 Global Active Pharmaceutical Ingredients Market-Company Profiles

  • 7.1. Aurobindo Pharma
  • 7.2. Mylan
  • 7.3. Teva Active Pharmaceutical Ingredients
  • 7.4. Ipca
  • 7.5. Aceto Corporation
  • 7.6. Arevipharma GmbH
  • 7.7. Dr. Reddy's
  • 7.8. Pfizer, Inc
  • 7.9. Novartis International AG
  • 7.10. Sanofi
  • 7.11. Ranbaxy
  • 7.12. Sun Pharma

8. Appendix

  • 8.1 Sources
  • 8.2 List of Tables
  • 8.3 Expert Panel Validation
  • 8.4 Disclaimer
  • 8.5 Contact Us
Back to Top